BioSpace News Archive

Drug Development

City of Hope scientists develop targeted chemotherapy able to kill all solid tumors in preclinical research

Researchers at City of Hope today published a new study explaining how they took a protein once thought to be too challenging for targeted therapy, proliferating cell nuclear antigen (PCNA), and developed a targeted chemotherapy that appears to annihilate all solid tumors in preclinical research.

August 1, 2023
·
5 min read
Braxia Scientific Reports Fiscal 2023 Financial Results

Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) (“Braxia Scientific”, or the “Company”), a medical research and telemedicine company with clinics providing innovative ketamine and psilocybin treatments for depression

August 1, 2023
·
8 min read
Business

Biotech Leader Carmine Stengone Joins Kiora Pharmaceuticals’ Board of Directors

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) has appointed Carmine Stengone as an independent member to the Company’s board of directors. Stengone currently serves as the President and CEO of Pipeline Therapeutics

August 1, 2023
·
5 min read
Awakn Life Sciences Completes Sale of Awakn Clinics In Norway

Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”) a clinical-stage biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD)

August 1, 2023
·
5 min read
AquaBounty Technologies Announces Second Quarter 2023 Financial Results

AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability

August 1, 2023
·
9 min read
Britannia Life Sciences Inc. Reports Fourth Quarter and Fiscal Year Financial Results

Britannia Life Sciences Inc. (CSE: BLAB) (“Britannia” or the “Company”) is pleased to provide its financial results for the year ended March 31, 2023.

August 1, 2023
·
3 min read
Business

Innoforce Strengthens Commercialization Leadership and Announces the Appointment of a New Chief Executive Officer

Zhejiang Innoforce Pharmaceuticals Co., Ltd., a CDMO company dedicated to providing one-stop-shop services to Advanced Therapy Medicinal Product customers and partners, announced Dr. Dewan Zeng as the new Chief Executive Officer, effective immediately.

August 1, 2023
·
2 min read
BioCapital

RegeneRx To Extend Consent Solicitation Vote

RegeneRx Biopharmaceuticals, Inc. announced that, pursuant to the company’s consent solicitation dated July 11, 2023, holders of 48.5% of the Company’s outstanding stock have voted to date, with 94% voting in favor of the proposed reverse stock split.

August 1, 2023
·
2 min read
Pharm Country

Orthoscan Announces End of Life for Orthoscan FD, FD-OR, Mobile DI, and FD Pulse Mini C-Arms

Orthoscan announced the End of Life plan for its Orthoscan FD, FD-OR, Mobile DI, and FD Pulse Mini C-Arms.

August 1, 2023
·
2 min read
FDA

RevBio Receives FDA Approval to Conduct its Second U.S.-Based Clinical Trial for Dental Implant Stabilization

RevBio has Developed a More Rapidly Resorbing Formulation of its Bone Adhesive Biomaterial for Implant Dentistry which will be Used in this Study.

August 1, 2023
·
4 min read